ZA200707012B - Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes - Google Patents
Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetesInfo
- Publication number
- ZA200707012B ZA200707012B ZA200707012A ZA200707012A ZA200707012B ZA 200707012 B ZA200707012 B ZA 200707012B ZA 200707012 A ZA200707012 A ZA 200707012A ZA 200707012 A ZA200707012 A ZA 200707012A ZA 200707012 B ZA200707012 B ZA 200707012B
- Authority
- ZA
- South Africa
- Prior art keywords
- rimonabant
- medicaments
- diabetes
- prevention
- preparation
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- JZCPYUJPEARBJL-UHFFFAOYSA-N rimonabant Chemical compound CC=1C(C(=O)NN2CCCCC2)=NN(C=2C(=CC(Cl)=CC=2)Cl)C=1C1=CC=C(Cl)C=C1 JZCPYUJPEARBJL-UHFFFAOYSA-N 0.000 title 1
- 229960003015 rimonabant Drugs 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0501861A FR2882261B1 (en) | 2005-02-21 | 2005-02-21 | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200707012B true ZA200707012B (en) | 2008-12-31 |
Family
ID=34954874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200707012A ZA200707012B (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101119727A (en) |
FR (1) | FR2882261B1 (en) |
ZA (1) | ZA200707012B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114452831B (en) * | 2022-01-24 | 2023-04-25 | 中南大学湘雅医院 | Surface-coated extracorporeal circulation modified membrane and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2789079B3 (en) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | PYRAZOLECARBOXYLIC ACID DERIVATIVE, ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
US20040122033A1 (en) * | 2002-12-10 | 2004-06-24 | Nargund Ravi P. | Combination therapy for the treatment of obesity |
-
2005
- 2005-02-21 FR FR0501861A patent/FR2882261B1/en not_active Expired - Fee Related
-
2006
- 2006-02-20 CN CNA2006800052531A patent/CN101119727A/en active Pending
- 2006-02-20 ZA ZA200707012A patent/ZA200707012B/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR2882261B1 (en) | 2009-02-06 |
FR2882261A1 (en) | 2006-08-25 |
CN101119727A (en) | 2008-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL195947A (en) | Fused cyclic compounds and pharmaceutical compositions comprising them for use in the prevention and treatment of diabetes | |
IL178822A (en) | 4-phenylamino-quinazolin-6-yl-amides, pharmaceutical compositions comprising the same and use thereof in the preparation of medicaments for the treatment of proliferative disorders | |
IL185462A0 (en) | New pharmaceutical compositions useful in the treatment of pain | |
IL231576A (en) | Adamantyl-acetamide derivatives, pharmaceutical compositions comprising same and use thereof in the manufacture of medicaments | |
IL188732A (en) | Use of ibuprofen and famotidine in the preparation of medicaments | |
IL181524A (en) | Heterocyclic compounds, pharmaceutical compositions containing them and their use in the manufacture of medicaments | |
HK1089376A1 (en) | Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions | |
IL206296A (en) | Aminopyrazole derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for prevention or treatment of diseases | |
IL194699A (en) | Tetrahydropteridines, compositions comprising them and use thereof in the preparation of medicaments | |
PL1912650T3 (en) | Use of flibanserin in the treatment of obesity | |
IL206080A0 (en) | Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases | |
EP2091540A4 (en) | Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain. | |
EP2164490A4 (en) | Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain. | |
GB0523576D0 (en) | Drug composition and its use in therapy | |
ZA201003037B (en) | Use of 3, 11b-cis-dihydrotettabenazine in the treatment of multiple sclerosis and autoimmune myelitis | |
IL194880A (en) | Aminothiazole derivatives, their use in the treatment of diseases and pharmaceutical compositions comprising them | |
IL178903A0 (en) | Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions | |
IL195441A0 (en) | Use of trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine and its formamide in the preparation of medicaments for the treatment of pain disorders | |
ZA200702421B (en) | Iron complex for use in the treatment and/or prevention of nutritional disorders | |
IL184697A (en) | Injectable preparation containing diclofenic, a process for its preparation and use of the preparation in the manufacture of medication for the relief of pain and/or inflammation | |
EP2005964A4 (en) | The medicament for treating hyperphospheremia and preparation thereof | |
IL201426A0 (en) | Drug combination and its use in the treatment of muscle loss | |
PL2193789T3 (en) | The application of 3,5-dihydroxytoluene or derivatives thereof in the preparation of medicine and functional food for treating or preventing depression | |
EP1944039A4 (en) | Drug for treating tumor and use thereof in the manufature of medicaments for treating tumor | |
ZA200707012B (en) | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |